Cross-species oncogenomics using zebrafish models of cancer.
Cross-species oncogenomics using zebrafish models of cancer.
复制标题
DOI:
10.1016/j.gde.2015.04.006
复制
发表时间:
2015-02
影响因子:
4
通讯作者:
White RM
中科院分区:
文献类型:
--
作者:
White RM
In recent years, the zebrafish has emerged as an important model in cancer biology. The fish was originally developed in the 1950s as a model for toxicity testing [2] but during the 1960s–1990s it emerged as a powerhouse of developmental genetics [4]. The realization that the zebrafish was amenable to ENU-based, forward genetic screens led to the eventual largescale effort to create large pools of mutant zebrafish each with a specific phenotype linked to an individual genetic mutation [5, 6]. Initially, many of these phenotypes centered around specific cell types or tissues [7] but it was recognized early on that the zebrafish was especially sensitive to neoplasia [8]. Many of these tumors developed spontaneously or in p53 deficient backgrounds [9] but could be rapidly accelerated by mutagens such as DMBA [10].The emergence of rapid and efficient transgenic technologies revolutionized the use of zebrafish in cancer research [11, 12]. Because each pair of fish mates rapidly and produce hundreds of embryos per day, it was clear that it was a model amenable to large scale, unbiased approaches to cancer phenotypes. In its most straightforward iteration, dominant acting oncogenes under cell-type specific promoters can be used to produce a wide variety of tumors such as melanoma, as shown in Figure 1 [1, 3, 13]. More recently, increasingly complex models of cancer have been developed using a variety of overexpression and knockout technologies. A range of the available cancer models in zebrafish is shown in Table 1.